Logos Global Management LP Janux Therapeutics, Inc. Transaction History
Logos Global Management LP
- $756 Million
- Q3 2024
A detailed history of Logos Global Management LP transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Logos Global Management LP holds 1,000,000 shares of JANX stock, worth $54.1 Million. This represents 6.01% of its overall portfolio holdings.
Number of Shares
1,000,000
Previous 750,000
33.33%
Holding current value
$54.1 Million
Previous $31.4 Million
44.6%
% of portfolio
6.01%
Previous 2.95%
Shares
7 transactions
Others Institutions Holding JANX
# of Institutions
166Shares Held
37.6MCall Options Held
85.3KPut Options Held
654K-
Ra Capital Management, L.P. Boston, MA9.17MShares$496 Million5.81% of portfolio
-
Janus Henderson Group PLC London, X02.52MShares$137 Million0.06% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.4MShares$130 Million3.93% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$127 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.08MShares$112 Million0.17% of portfolio
About Janux Therapeutics, Inc.
- Ticker JANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,663,000
- Market Cap $2.25B
- Description
- Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...